ENTITY
SK Biopharmaceuticals

SK Biopharmaceuticals (326030 KS)

174
Analysis
Health Care • South Korea
SK Biopharmaceuticals Co., Ltd. researches and develops new drugs. The Company develops and markets brain disorders treatment drugs, central nervous system disorders treatment drugs, and other products. SK Biopharmaceuticals markets its products worldwide.
more
Company Event • 06 Nov 2026 14:00 • Upcoming
Add To Calendar

Q3 2026

Company Event • 14 Aug 2026 08:00 • Upcoming
Add To Calendar

Q2 2026

Company Event • 27 May 2026 14:00 • Upcoming
Add To Calendar

Investor presentation

Company Event • 15 May 2026 08:00 • Upcoming
Add To Calendar

Q1 2026

Company Event • 18 Mar 2026 08:00 • Upcoming
Add To Calendar

Q4 2025

x